<DOC>
	<DOC>NCT02729740</DOC>
	<brief_summary>The primary objective of this study is to gather post market data on the Penumbra SMART Coilâ„¢ System in the treatment of intracranial aneurysms and other malformations.</brief_summary>
	<brief_title>Assessment of the Embolization of Neurovascular Lesions Using the Penumbra Smart Coil</brief_title>
	<detailed_description>This is a prospective, multi-center study of patients treated in accordance with the cleared indications for the Penumbra SMART CoilTM System (Smart), Penumbra Coil 400TM (PC 400), and Penumbra Occlusion DeviceTM (POD). Data for each patient are collected in accordance with the standard of care at each participating hospital through one-year follow-up. Approximately 1,000 patients with intracranial aneurysms or other malformations treated by the SMART CoilTM System at up to 100 centers will be enrolled. It is anticipated patient enrollment will take 3 years. All patients are to be assessed in accordance with the standard of care at each participating hospital through one year follow-up.</detailed_description>
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Intracranial Aneurysm</mesh_term>
	<criteria>Patients enrolled in this study must sign Informed Consent and be treated according to the cleared indications for the Smart, PC 400, and POD, which include the embolization of: Intracranial aneurysms Other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulae Life expectancy less than one year Smart, PC 400, or POD account for less than 75% of total number of coils opened Participation in another clinical investigation that could confound the evaluation of the study device</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Penumbra Smart coils</keyword>
	<keyword>PC 400</keyword>
	<keyword>AV malformations</keyword>
	<keyword>AV fistulae</keyword>
</DOC>